Literature DB >> 12649713

Use of time-trend analysis in the design of empirical antimicrobial treatment of urinary tract infection.

D Raveh1, B Rudensky, M Huerta, Y Aviv, A M Yinnon.   

Abstract

Selection of empirical treatment of hospitalized patients with urinary tract infection (UTI) is usually based on the results of urine culture as obtained from the local microbiology laboratory. In order to improve the precision and reliability of traditional methods, we analyzed temporal changes in the results of urine culture and antibiograms and stratified the results by inpatient department and the presence/absence of an indwelling catheter. The database consisted of urine cultures obtained during the first 3 months of each year over a 10-year period between 1991 and 2000. Only urine samples that grew a single organism at a concentration of >10(5) cfu were included in the analysis. Trend statistical tools, readily available but thus far not used for microbiological analyses, were applied to assess the decay in activity of individual antibiotic agents over time and to calculate susceptibility rates of organisms in subsets of urine samples. Organisms, antimicrobial susceptibility rates and the degree of decay in antimicrobial susceptibility rates varied significantly according to the location of the patient in the hospital and the presence of an indwelling catheter. Stratified trend analysis is a useful tool that can be helpful in designing and adapting clinical guidelines for the selection of appropriate empirical antibiotic treatment for the individual patient with urinary tract infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649713     DOI: 10.1007/s10096-003-0905-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  17 in total

Review 1.  Increasing antimicrobial resistance and the management of uncomplicated community-acquired urinary tract infections.

Authors:  K Gupta; T M Hooton; W E Stamm
Journal:  Ann Intern Med       Date:  2001-07-03       Impact factor: 25.391

2.  Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis pyelonephritis in women: a randomized trial.

Authors:  D A Talan; W E Stamm; T M Hooton; G J Moran; T Burke; A Iravani; J Reuning-Scherer; D A Church
Journal:  JAMA       Date:  2000 Mar 22-29       Impact factor: 56.272

3.  In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus.

Authors:  E Tallis; B Rudensky; D Attias; D Raveh; Y Schlesinger; A M Yinnon
Journal:  Diagn Microbiol Infect Dis       Date:  1999-10       Impact factor: 2.803

Review 4.  Diagnosis and treatment of uncomplicated urinary tract infection.

Authors:  T M Hooton; W E Stamm
Journal:  Infect Dis Clin North Am       Date:  1997-09       Impact factor: 5.982

Review 5.  Management of urinary tract infections in adults.

Authors:  W E Stamm; T M Hooton
Journal:  N Engl J Med       Date:  1993-10-28       Impact factor: 91.245

6.  A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin Urinary Tract Infection Group.

Authors:  J M McCarty; G Richard; W Huck; R M Tucker; R L Tosiello; M Shan; A Heyd; R M Echols
Journal:  Am J Med       Date:  1999-03       Impact factor: 4.965

7.  Empiric antibiotic treatment and the misuse of culture results and antibiotic sensitivities in patients with community-acquired bacteraemia due to urinary tract infection.

Authors:  G Elhanan; M Sarhat; R Raz
Journal:  J Infect       Date:  1997-11       Impact factor: 6.072

8.  The effectiveness of a clinical practice guideline for the management of presumed uncomplicated urinary tract infection in women.

Authors:  S Saint; D Scholes; S D Fihn; R G Farrell; W E Stamm
Journal:  Am J Med       Date:  1999-06       Impact factor: 4.965

9.  Epidemiology of community-acquired Pseudomonas aeruginosa infections in children.

Authors:  I Paraskaki; E Lebessi; N J Legakis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-10       Impact factor: 3.267

10.  Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center.

Authors:  L B Rice; E C Eckstein; J DeVente; D M Shlaes
Journal:  Clin Infect Dis       Date:  1996-07       Impact factor: 9.079

View more
  2 in total

1.  Risk factors for bacteriuria due to Pseudomonas aeruginosa or Enterococcus spp in patients hospitalized via the emergency department.

Authors:  D Raveh; I Rosenzweig; B Rudensky; Y Wiener-Well; A M Yinnon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-05       Impact factor: 3.267

2.  Risk factors for bacteriuria with carbapenem-resistant Klebsiella pneumoniae and its impact on mortality: a case-control study.

Authors:  S Shilo; M V Assous; T Lachish; P Kopuit; T Bdolah-Abram; A M Yinnon; Y Wiener-Well
Journal:  Infection       Date:  2012-12-28       Impact factor: 3.553

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.